Project
Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.
| Reference: | 644167 |
|---|---|
| Financing program: | H2020 |
| Funding organization: | European Commission |
| Associated institutions: | Universidade de Lisboa |
Similar Items
Antimicrobial peptides against bacterial pathogens.
NEWPATH: New Advances on Synergistic Antibacterial Coatings Against Pathogenic Bacteria.
New advance in biomedicine: peptide-mediated target drug delivery
Towards the development of antimicrobial peptides with antibacterial activity against resistant bacteria and bacterial biofilms
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
TARGETING TUMORS WITH INNOVATIVE METAL PEPTIDE COMPLEXAS: IMPROVING EFFICACY IN ANTICANCER DRUGS
Development of adjustable Silver@Silica nanocarriers and their stabilization in solid materials against drug resistant and non-resistant pathogenic bacteria. Towards advanced nano-antibiotics, wound dressing and anti-biofilm surfaces
HIGH-THROUGHPUT CLONING OF VENOM PEPTIDES FOR DISCOVERY OF NOVEL THERAPEUTIC PEPTIDES AND INNOVATIVE DRUG DEVELOPMENT
Development of Peptides for Cancer Diagnostics
Towards the development of antimicrobial peptides active against bacterial biofilms
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
DRUG DELIVERY: DEVELOPMENT OF TARGETED FUNCTIONAL PARTICLES FOR CANCER THERAPY
TOWARDS IMPROVED PRODUCTION OF COMPLEX BIOPHARMACEUTICALS THROUGH SYSTEMS BIOTECHNOLOGY
Phage-Enzybiotic: dealing with critical pathogenic antibiotic-resistant bacteria
TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles
Targeting brain-resident viruses across the blood-brain barrier using peptide drugs.
INTEGRATION OF GENOMIC AND STRUCTURAL INFORMATION TO CHOOSE NEW THERAPEUTICAL TARGETS AND DEVELOP NEW DRUGS AGAINST MALARIA
Lipid signaling in grapevine resistance against fungal pathogens
ROLE OF THE MICROBIOTA IN THE DEFENSE AGAINST ANTIBIOTIC RESISTANT PATHOGENS
Broad-spectrum antiviral peptides against respiratory viruses
Smart ruthenium-peptide prodrugs: a ray of hope in the battle against metastatic breast cancer
Discovery of new antimicrobial drugs active against resistant pathogen agents: The case study of Portuguese Asphodelus species
Engineering fusion inhibitor peptides against childhood respiratory viruses
BMX-targeted ligand-drug conjugates for prostate cancer therapy
Viral surface glycoproteins as potential drug targets against HIV-1 and HIV-2 infections
Trans-BBB peptides for targeting brain metastasis
Advances in MUC1 Glycan Cancer Antigens: From structure to function in the fight against cancer
MICROENCAPSULATED LIPID NANOPARTICLES FOR PULMONARY DELIVERY OF BIOPHARMACEUTICAL AGENTS
TRPV1-targeted ligand-drug conjugates to treat prostate cancer
Modulation and targeting of calcium channels with ligand-drug conjugates for cancer therapy
Integrated Training in Dry Eye Disease Drug Development (IT-DED3)
Detoxification of Hydrogen Peroxide by Pathogenic Bacteria - E.coli Tri-haem peroxidase as a model
Innovative drugs targeting IDO molecular dynamics in autoimmunity and neoplasia [338954]
A nanotechnology approach to Flavivirus-targeted drug development strategies
A nanotechnology approach to Flavivirus-targeted drug development strategies
Endo- and epiphytic bacteria from olive tree phyllosphere with biocontrol abilities against olive knot
Pathogenic bacteria of wild animals - antimicrobial resistance genes flux and potential impact in animal and human health
Insights into novel bacterial cytochrome c peroxidases from pathogenic bacteria, Neisseria gonorrhoeae and Escherichia coli
European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis
Related publications
Loading publications...